tiprankstipranks
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Cash flow

67 Followers

Revelation Biosciences Cash Flow

REVB's free cash flow for Q1 2024 was $-2.86M. For the 2024 fiscal year, REVB's free cash flow was decreased by $-10.49M and operating cash flow was $-2.84M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20
Operating Cash Flow
$ -8.12M$ -11.22M$ -725.62K$ -1.42M
Investing Cash Flow
$ -19.17K-$ 25.74M-
Financing Cash Flow
$ 19.44M$ 15.20M$ -24.95M$ 5.91M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ 58.19M$ 5.25M$ 78.53K$ 4.49M
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
----
Issuance Of Capital Stock
---$ 5.91M
Issuance Of Debt
--$ 750.00K-
Repayment Of Debt
-$ -2.50M--
Free Cash Flow
$ -8.14M$ -11.22M$ -725.62K$ -1.42M
Domestic Sales
----
Foreign Sales
----
Currency in USD

Revelation Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis